What is the recommended treatment for hyperpigmentation (dark spots) on the bridge of the nose and glabella?

Treatment of Hyperpigmentation on the Bridge of the Nose and Glabella

Start with triple combination cream (hydroquinone 4%, tretinoin 0.05%, and fluocinolone acetonide 0.01%) applied nightly to affected areas, combined with daily broad-spectrum SPF 50+ sunscreen reapplied every 2-3 hours during sun exposure. 1, 2

First-Line Topical Therapy

The American Academy of Dermatology identifies triple combination formulations as the most effective topical regimen for facial hyperpigmentation. 1 This approach targets multiple points in the melanin production cycle:

• Apply triple combination cream (hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%) once nightly to the bridge of the nose and glabella 1, 2
• Hydroquinone remains the gold standard bleaching agent, inhibiting tyrosinase to reduce melanin production 3, 4
• Tretinoin enhances epidermal turnover and can be used alone or combined with hydroquinone for superior efficacy 1, 3
• Corticosteroid component reduces irritation and enhances penetration of active ingredients 2

Alternative first-line agents if triple combination is unavailable or contraindicated:

• Azelaic acid 15-20% is particularly effective for darker skin types (Fitzpatrick III-VI) due to its dual action on dyspigmentation and low irritation profile 1, 4
• Kojic acid or mequinol as alternative tyrosinase inhibitors 3, 4

Essential Sun Protection (Non-Negotiable)

Sun protection is the foundation of any hyperpigmentation treatment and must be maintained throughout therapy. 1, 2, 5

• Apply broad-spectrum SPF 50+ sunscreen daily to the entire face, with reapplication every 2-3 hours during outdoor exposure 1, 2
• Wear wide-brimmed hats (>3-inch brim) when outdoors 2
• Seek shade during peak UV hours (10 a.m. to 4 p.m.) 2
• Even minimal sunlight sustains melanocytic activity and will reverse treatment gains 5

Treatment Timeline and Monitoring

• Expect visible improvement within 6-12 weeks of consistent topical therapy 1, 6
• Use modified Melasma Area and Severity Index (mMASI) scores to objectively track improvement every 4-6 weeks 1, 2
• Do not discontinue corticosteroids abruptly; limit continuous use to 2 months maximum to avoid skin atrophy 1, 7

Second-Line Therapy for Inadequate Response After 3 Months

If first-line topical therapy fails to produce >60% improvement after 3 months of compliant use:

Add oral tranexamic acid 250 mg twice daily for refractory hyperpigmentation 1, 2

• This systemic approach inhibits melanocyte activation through plasmin inhibition 1, 6
• Particularly effective when combined with continued topical therapy 2

Advanced Procedural Options (Third-Line)

For persistent hyperpigmentation despite 6 months of medical therapy:

Intradermal platelet-rich plasma (PRP) injections:

• Administer 4 treatment sessions spaced every 2-3 weeks 2
• Inject intradermally at 1 cm intervals across the bridge of the nose and glabella 2
• PRP demonstrates significantly better results than intradermal tranexamic acid with similar safety profiles 2
• Expect improvement within 6 weeks as measured by mMASI scores 1, 2
• Maintenance treatments every 6 months are required as hyperpigmentation is a chronic condition 2

Microneedling with PRP:

• Apply PRP BEFORE microneedling (not after) to maximize efficacy—the needling action drives growth factors into the skin 2
• Use needle depth of 0.5-2.0 mm depending on skin thickness 2
• Apply topical anesthetic 30 minutes before the procedure 2
• Microneedling carries very low risk of post-inflammatory hyperpigmentation compared to laser therapy, especially in darker skin types 2
• Minimal downtime of 24-48 hours 2

Critical Safety Considerations and Contraindications

Hydroquinone-containing products are contraindicated in:

• Pregnancy (tretinoin is Category C) 2, 5
• Nursing mothers (unknown excretion into breast milk) 5
• Children <12 years (safety not established) 5
• Known hypersensitivity to any component 2, 5

Expected adverse effects:

• Mild erythema, peeling, dryness, burning at application site (generally transient) 2, 5
• Avoid concomitant use of other photosensitizing or keratolytic agents 5

Common Pitfalls to Avoid

• Do NOT use laser therapy on the bridge of the nose in patients with Fitzpatrick skin types IV-VI due to markedly higher risk of burns, post-inflammatory hyperpigmentation, and permanent hypopigmentation 2
• Do NOT apply topical agents after microneedling—this provides no benefit and is a critical procedural error 2
• Do NOT forget sunscreen reapplication after swimming, sweating, or after 2-3 hours of continuous exposure 2
• Do NOT discontinue treatment prematurely—hyperpigmentation is a chronic condition requiring long-term maintenance therapy even after clearance 2
• Do NOT exceed 2 months of continuous topical corticosteroid use to prevent skin atrophy 1, 7
• Do NOT use cryotherapy on the bridge of the nose—this area should be avoided due to risk of keloid formation and permanent pigmentary changes 8

Treatment Algorithm Summary

1. Weeks 0-12: Triple combination cream nightly + SPF 50+ daily
2. If <60% improvement at 12 weeks: Add oral tranexamic acid 250 mg twice daily
3. If <60% improvement at 24 weeks: Add intradermal PRP (4 sessions over 8 weeks) OR microneedling with PRP
4. Maintenance phase: Continue sunscreen indefinitely; PRP maintenance every 6 months; consider maintenance topical therapy 2-3 times weekly 2

Counsel patients that genetic factors, hormonal influences (oral contraceptives, pregnancy), and smoking may limit treatment success and require realistic expectations. 1, 2